243 related articles for article (PubMed ID: 22778345)
21. Building sustainable organizational capacity to deliver HIV programs in resource-constrained settings: stakeholder perspectives.
Sharma A; Chiliade P; Michael Reyes E; Thomas KK; Collens SR; Rafael Morales J
Glob Health Action; 2013 Dec; 6():22571. PubMed ID: 24331715
[TBL] [Abstract][Full Text] [Related]
22. Palliative care and support for persons with HIV/AIDS in 7 African countries: implementation experience and future priorities.
Alexander CS; Memiah P; Henley YB; Kaiza-Kangalawe A; Shumbusho AJ; Obiefune M; Enejoh V; Stanis-Ezeobi W; Eze C; Odion E; Akpenna D; Effiong A; Miriti K; Aduda S; Oko J; Melaku GD; Baribwira C; Umutesi H; Shimabale M; Mugisa E; Amoroso A
Am J Hosp Palliat Care; 2012 Jun; 29(4):279-85. PubMed ID: 21998442
[TBL] [Abstract][Full Text] [Related]
23. The effectiveness of PEPFAR's funding for women and children with HIV/AIDS.
Kim Y
Int J Health Plann Manage; 2019 Jan; 34(1):e896-e916. PubMed ID: 30451315
[TBL] [Abstract][Full Text] [Related]
24. A clinician's experience with the President's Emergency Plan for AIDS Relief in Nigeria: a transformative decade of hope.
Idoko J
Health Aff (Millwood); 2012 Jul; 31(7):1422-8. PubMed ID: 22778331
[TBL] [Abstract][Full Text] [Related]
25. AIDS. Resource needs for HIV/AIDS.
Schwartländer B; Stover J; Walker N; Bollinger L; Gutierrez JP; McGreevey W; Opuni M; Forsythe S; Kumaranayake L; Watts C; Bertozzi S
Science; 2001 Jun; 292(5526):2434-6. PubMed ID: 11423619
[No Abstract] [Full Text] [Related]
26. Countries where HIV is concentrated among most-at-risk populations get disproportionally lower funding from PEPFAR.
Grosso AL; Tram KH; Ryan O; Baral S
Health Aff (Millwood); 2012 Jul; 31(7):1519-28. PubMed ID: 22778341
[TBL] [Abstract][Full Text] [Related]
27. PEPFAR programs linked to more deliveries in health facilities by African women who are not infected with HIV.
Kruk ME; Jakubowski A; Rabkin M; Elul B; Friedman M; El-Sadr W
Health Aff (Millwood); 2012 Jul; 31(7):1478-88. PubMed ID: 22778337
[TBL] [Abstract][Full Text] [Related]
28. Ghana's HIV epidemic and PEPFAR's contribution towards epidemic control.
Ali H; Amoyaw F; Baden D; Durand L; Bronson M; Kim A; Grant-Greene Y; Imtiaz R; Swaminathan M
Ghana Med J; 2019 Mar; 53(1):59-62. PubMed ID: 31138945
[TBL] [Abstract][Full Text] [Related]
29. Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.
Beck EJ; Santas XM; Delay PR
AIDS; 2008 Jul; 22 Suppl 1():S75-85. PubMed ID: 18664958
[TBL] [Abstract][Full Text] [Related]
30. Mapping the impact of the expanded Mexico City Policy for HIV/ family planning service integration in PEPFAR-supported countries: a risk index.
Sherwood J; Sharp A; Honermann B; Horrigan C; Chatterjee M; Jones A; Cooney C; Millett G
BMC Public Health; 2018 Sep; 18(1):1116. PubMed ID: 30208876
[TBL] [Abstract][Full Text] [Related]
31. District Health Officer Perceptions of PEPFAR's Influence on the Health System in Uganda, 2005-2011.
Lohman N; Hagopian A; Luboga SA; Stover B; Lim T; Makumbi F; Kiwanuka N; Lubega F; Ndizihiwe A; Mukooyo E; Barnhart S; Pfeiffer J
Int J Health Policy Manag; 2017 Feb; 6(2):83-95. PubMed ID: 28812783
[TBL] [Abstract][Full Text] [Related]
32. Tackling HIV and gender-based violence in South Africa: how has PEPFAR responded and what are the implications for implementing organizations?
Ghanotakis E; Mayhew S; Watts C
Health Policy Plan; 2009 Sep; 24(5):357-66. PubMed ID: 19505995
[TBL] [Abstract][Full Text] [Related]
33. PEPFAR Investments In Governance And Health Systems Were One-Fifth Of Countries' Budgeted Funds, 2004-14.
Moucheraud C; Sparkes S; Nakamura Y; Gage A; Atun R; Bossert TJ
Health Aff (Millwood); 2016 May; 35(5):847-55. PubMed ID: 27140991
[TBL] [Abstract][Full Text] [Related]
34. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
Abramowitz S; Greene D
AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
[TBL] [Abstract][Full Text] [Related]
35. The way forward: maximizing our impact through shared responsibility and smart investments.
Goosby E
J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 2():S44-7. PubMed ID: 22772391
[TBL] [Abstract][Full Text] [Related]
36. Can AIDS prevention move to sufficient scale?
Slutkin G
Netw Res Triangle Park N C; 1993 May; 13(4):16-7. PubMed ID: 12344870
[TBL] [Abstract][Full Text] [Related]
37. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
Kerouedan D
Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
[TBL] [Abstract][Full Text] [Related]
38. Addressing advanced HIV disease and mortality in global HIV programming.
Boyd AT; Oboho I; Paulin H; Ali H; Godfrey C; Date A; Sean Cavanaugh J
AIDS Res Ther; 2020 Jul; 17(1):40. PubMed ID: 32650797
[TBL] [Abstract][Full Text] [Related]
39. The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomes.
Bendavid E; Bhattacharya J
Ann Intern Med; 2009 May; 150(10):688-95. PubMed ID: 19349625
[TBL] [Abstract][Full Text] [Related]
40. Bridging the resource gap: improving value for money in HIV/AIDS treatment.
Soni A; Gupta R
Health Aff (Millwood); 2009; 28(6):1617-28. PubMed ID: 19887403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
